⏰Reminder: The 2nd Annual #DCIS Patient Forum will be held virtually this Saturday, May 18th at 9 am!
Register today and join us👇redcap.partners.org/redcap/surveys…
Dr. E Mittendorf Stuart Schnitt jennifer bellon
Brittany Bychkovsky, MD Tari King MD Nancy Campbell Dana-Farber Dana-FarberNews

Discussing important clinical trial design challenges in breast cancer! - Stefan Michiels
ESMO - Eur. Oncology Sara Tolaney Tatiana Prowell, MD Tomás Pascual Erika Hamilton, MD MarleenKokLab
oncodaily.com/66859.html

#BreastCancer #Cancer #ESMO #OncoDaily #Oncology #TheNetherlandsCancerInstitute

It was my first time at ESMO - Eur. Oncology #breast2024 in Berlin. Nice sessions, social Activity, new friends, and final session on the management of brain metastases with dr LeRhun and Nancy Lin, MD,

Congratulations to Sara Tolaney, MD, MPH Sara Tolaney DF/HCC on her appointment as Alliance for Clinical Trials in Oncology Breast Committee Vice-Chair! #AllianceSpring24 #NCI #NCTN #CancerResearch

What are some of the new advances that have occurred in triple-negative #breast cancer ( #TNBC ) this year? Watch as Sara Tolaney of Dana-Farber shares updates on clinical #trials and new treatment directions to look forward to!

oncdata.com/additional-adv…

#breast cancer #bcsm #CME

Thanks ⁦Harvard T.H. Chan School of Public Health⁩ MPH in Epidemiology for the spotlight! 😊Incredibly excited to graduate next week with all my amazing classmates! 👩🏼‍🎓 linkedin.com/posts/harvard-…

Dr. Nancy Lin (Nancy Lin, MD) discussed advances in medical treatment in today's #ESMObreast24 educational session on the management of #BrainMetastases from early detection to local and systemic treatments.
#BreastCancerBrainMetastasis #BCBM #LMD
cattendee.abstractsonline.com/meeting/20743/…

Important point by Erika Hamilton, MD. A common questions from pts is: what should I take (or eat) to reduce my risk of recurrence? The answer to this question should not come from retrospective studies, often burdened by confounding bias, but should derive from RCTs. #ESMOBreast24

Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos. #ESMOBreast24 #ESMOAmbassadors ESMO - Eur. Oncology

Important message for treatm of ILC! #ESMOBreast24

#ESMObreast24 key takeaways in early detection and prevention by Suzette Delaloge
OncoAlert

#ESMOBreast24 : Two studies on #SexualHealth in #BC provide new insights into the effects of vaginal oestrogen therapy and physical exercise to tackle sexual impairment.
Read Don S. Dizon MD (he/him) 🇬🇺’s analysis on #ESMODailyReporter
👉ow.ly/juBi50RJrbQ

Updated data for Pfizer cdk4-selective inhibitor PF-07220060
-pt population: 100% prior cdk4/6i
-favorable tox profile
-32% ORR, median PFS 8.1 mo
-efficacy regardless of ESR1 and PIK3CA mutation status

⏰Reminder: The 2nd Annual #DCIS Patient Forum will be held virtually this Saturday, May 18th at 9 am!
Register today and join us👇redcap.partners.org/redcap/surveys…
Dr. E Mittendorf Stuart Schnitt jennifer bellon
Brittany Bychkovsky, MD Tari King MD Nancy Campbell Dana-Farber Dana-FarberNews

Great work led by Ilana Schlam building on important work done by Dario Trapani and colleagues. Collaboration is key always, but in particular in rare diseases such as IBC.

#ESMODailyReporter discussed a global study looking at pregnancy after #BreastCancer which found that assisted reproductive techniques following cancer treatment have proven to be safe in women with breast cancer
#ESMOBreast24 Ann Partridge MD, MPH Matteo Lambertini, MD PhD
dailyreporter.esmo.org/esmo-breast-ca…

Don't miss Dr. Nancy Lin (Nancy Lin, MD) discussing advanced medical treatment in the management of #BrainMetastases .
🗓️Friday, May 17th
⏰11:30-11:50 CEST / 5:30-5:50 am EST
📍Hamburg Hall / Online

As we front-load more treatments (e.g. chemo/IO in TNBC, chemo/HP/TMD1 in HER2+, chemo/CDK4/6i in ER+) for early stage breast cancer, those tumors that do recur are progressively resistant to the current options in MBC.

Great presentation by Benjamin Walbaum, MD and incredible discussion by Sara Tolaney !!

Truly an honor to be in the same stage with Sara Tolaney Thanks ESMO - Eur. Oncology for the opportunity for an oncologist from 🇦🇷